| Primary |
| Type 2 Diabetes Mellitus |
36.5% |
| Diabetes Mellitus |
13.7% |
| Type 1 Diabetes Mellitus |
12.1% |
| Product Used For Unknown Indication |
10.7% |
| Device Therapy |
9.9% |
| Blood Pressure |
3.3% |
| Diabetic Neuropathy |
2.5% |
| Hypertension |
1.9% |
| Diabetes |
1.6% |
| Asthma |
1.4% |
| Drug Use For Unknown Indication |
0.8% |
| Rheumatoid Arthritis |
0.8% |
| Thyroid Disorder |
0.8% |
| Angioplasty |
0.5% |
| Atrial Fibrillation |
0.5% |
| Gastric Disorder |
0.5% |
| Hypothyroidism |
0.5% |
| Pain |
0.5% |
| Parkinson's Disease |
0.5% |
| Prophylaxis Urinary Tract Infection |
0.5% |
|
| Device Malfunction |
41.3% |
| Wrong Drug Administered |
21.2% |
| Product Quality Issue |
15.9% |
| Weight Increased |
2.6% |
| Diabetic Ketoacidosis |
2.1% |
| Asthenia |
1.6% |
| Cataract |
1.6% |
| Hyperglycaemia |
1.6% |
| Hypoglycaemia |
1.6% |
| Road Traffic Accident |
1.6% |
| Blood Glucose Decreased |
1.1% |
| Drug Ineffective |
1.1% |
| Headache |
1.1% |
| Malaise |
1.1% |
| Tremor |
1.1% |
| Visual Impairment |
1.1% |
| Weight Decreased |
1.1% |
| Abdominal Pain Upper |
0.5% |
| Adverse Event |
0.5% |
| Alanine Aminotransferase Increased |
0.5% |
|
| Secondary |
| Type 2 Diabetes Mellitus |
41.9% |
| Type 1 Diabetes Mellitus |
16.4% |
| Device Therapy |
11.3% |
| Diabetes Mellitus |
9.8% |
| Hypertension |
5.7% |
| Blood Pressure |
1.5% |
| Diabetes |
1.3% |
| Product Used For Unknown Indication |
1.3% |
| Anticoagulant Therapy |
1.1% |
| Depression |
1.1% |
| Vitamin Supplementation |
1.1% |
| Gastrooesophageal Reflux Disease |
1.0% |
| Gestational Diabetes |
1.0% |
| Prophylaxis |
1.0% |
| Diabetic Neuropathy |
0.8% |
| Insomnia |
0.8% |
| Osteoporosis |
0.8% |
| Parkinson's Disease |
0.8% |
| Prophylaxis Urinary Tract Infection |
0.8% |
| Blood Cholesterol |
0.6% |
|
| Wrong Drug Administered |
31.1% |
| Premature Baby |
6.7% |
| Vomiting |
6.7% |
| Respiratory Tract Infection |
5.6% |
| Weight Decreased |
5.6% |
| Drug Exposure During Pregnancy |
4.4% |
| Tremor |
4.4% |
| Death |
3.3% |
| Hypoglycaemia |
3.3% |
| Malaise |
3.3% |
| Product Quality Issue |
3.3% |
| Visual Acuity Reduced |
3.3% |
| Visual Impairment |
3.3% |
| Asthenia |
2.2% |
| Blood Glucose Fluctuation |
2.2% |
| Cold Sweat |
2.2% |
| Depressed Level Of Consciousness |
2.2% |
| Foetal Exposure During Pregnancy |
2.2% |
| Injection Site Pain |
2.2% |
| Injury Associated With Device |
2.2% |
|
| Concomitant |
| Diabetes Mellitus |
22.5% |
| Product Used For Unknown Indication |
16.7% |
| Prophylaxis |
10.6% |
| Gastrointestinal Disorder |
7.9% |
| Pain |
5.3% |
| Upper Respiratory Tract Infection |
5.3% |
| Blood Pressure |
3.5% |
| Hypertension |
3.5% |
| Type 2 Diabetes Mellitus |
3.5% |
| Antiretroviral Therapy |
2.6% |
| Candidiasis |
2.6% |
| Cytomegalovirus Infection |
2.6% |
| Liver Disorder |
2.6% |
| Prostatic Disorder |
2.6% |
| Hiv Infection |
2.2% |
| Anticoagulant Therapy |
1.3% |
| Blood Cholesterol Increased |
1.3% |
| Blood Triglycerides Abnormal |
1.3% |
| Bone Disorder |
0.9% |
| Depression |
0.9% |
|
| Prostatic Disorder |
11.5% |
| Device Malfunction |
7.7% |
| Duodenitis |
7.7% |
| Eye Disorder |
7.7% |
| Injection Site Haemorrhage |
7.7% |
| Liver Disorder |
7.7% |
| Cardiac Disorder |
3.8% |
| Chest Discomfort |
3.8% |
| Endocrine Disorder |
3.8% |
| Femur Fracture |
3.8% |
| Hyperglycaemia |
3.8% |
| Injection Site Haematoma |
3.8% |
| Insomnia |
3.8% |
| Metabolic Acidosis |
3.8% |
| Nausea |
3.8% |
| Parathyroid Disorder |
3.8% |
| Renal Failure Acute |
3.8% |
| Renal Impairment |
3.8% |
| Swollen Tongue |
3.8% |
|
| Interacting |
| Atrial Fibrillation |
100.0% |
|
| Hypoglycaemic Coma |
100.0% |
|
